Cargando…

Treatment of Central Nervous System Infection Caused by Multidrug-Resistant Klebsiella pneumoniae with Colistin Sulfate Intravenously and Intrathecally: A Case Report

Background: Due to the blood–brain barrier and limited antibiotic choices, polymyxin is currently the first-line agent for the treatment of central nervous system infections (CNSIs) caused by multidrug-resistant Gram-negative bacteria (MDR-GNB). Colistin sulfate, as a polymyxin E different from CMS,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Xin, Zhong, Cejun, Chen, Haifeng, Xie, Xiaoqi, Lv, Xiaoju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787966/ https://www.ncbi.nlm.nih.gov/pubmed/36558933 http://dx.doi.org/10.3390/ph15121482

Ejemplares similares

482 Intrathecal Colistin Therapy to Treat Multidrug Resistant Gram Negative Central Nervous System Infection
por: Mukherjee, Dip Narayan
Publicado: (2014)

Treatment of Central Nervous System Infection Caused by Multidrug-Resistant Acinetobacter baumannii with Intravenous and Intraventricular Colistin Sulfate: A Case Report and Literature Review
por: Yang, Xueping, et al.
Publicado: (2023)

Multidrug-resistant Acinetobacter meningitis treated by intrathecal colistin
por: Singh, Rajesh K., et al.
Publicado: (2017)

Intrathecal or Intraventricular Tigecycline Therapy for Central Nervous System Infection Associated with Carbapenem-Resistant Klebsiella pneumoniae
por: Du, Ning, et al.
Publicado: (2022)

Intrathecal administration of colistin, vancomycin and amikacin for central nervous system infections in ICU neurosurgical patients
por: Alexandropoulos, P, et al.
Publicado: (2015)

Outcomes in meningitis‑ventriculitis treated with intravenous or intrathecal plus intravenous colistin: A meta‑analysis
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Draft Genome Sequences of Two Multidrug Resistant Klebsiella pneumoniae ST258 Isolates Resistant to Colistin
por: Comandatore, Francesco, et al.
Publicado: (2013)

Genome Sequences of Multidrug-Resistant, Colistin-Susceptible and -Resistant Klebsiella pneumoniae Clinical Isolates from Pakistan
por: Crawford, Matthew A., et al.
Publicado: (2016)

Intravenous Colistin in the treatment of multidrug-resistant Acinetobacter in neonates
por: Al-lawama, Manar, et al.
Publicado: (2016)

Colistin for Treatment of Multidrug Resistant Central Nervous System Infection: A Triple Route Therapy!
por: Shukla, Ratnesh Kumar, et al.
Publicado: (2019)

The Occurence of Colistin-Resistant Hypervirulent Klebsiella pneumoniae in China
por: Lu, Yang, et al.
Publicado: (2018)

Emergence of colistin resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli strains isolated from cancer patients
por: Zafer, Mai M., et al.
Publicado: (2019)

Efficacy and safety of polymyxin E sulfate in the treatment of critically ill patients with carbapenem-resistant organism infections
por: Lu, Xin, et al.
Publicado: (2022)

Prevalence of the colistin resistance gene MCR-1 in colistin-resistant Klebsiella pneumoniae in Egypt
por: Abozahra, Rania, et al.
Publicado: (2023)

Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Ayerbe-Algaba, Rafael, et al.
Publicado: (2018)

Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates
por: Stein, Claudia, et al.
Publicado: (2015)

Quercetin Rejuvenates Sensitization of Colistin-Resistant Escherichia coli and Klebsiella Pneumoniae Clinical Isolates to Colistin
por: Lin, Yishuai, et al.
Publicado: (2021)

Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates
por: Lomonaco, Sara, et al.
Publicado: (2018)

Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future
por: Petrosillo, Nicola, et al.
Publicado: (2019)

Resistance to Colistin in Klebsiella Pneumoniae: A 4.0 Strain?
por: Granata, Guido, et al.
Publicado: (2017)

A Bibliometric Meta-Analysis of Colistin Resistance in Klebsiella pneumoniae
por: Nwabor, Ozioma Forstinus, et al.
Publicado: (2021)

Colistin Resistance Mechanisms in Human and Veterinary Klebsiella pneumoniae Isolates
por: Tietgen, Manuela, et al.
Publicado: (2022)

Combination Treatment with Intravenous Tigecycline and Intraventricular and Intravenous Colistin in Postoperative Ventriculitis Caused by Multidrug-resistant Acinetobacter baumannii
por: Mizrahi, Cezar J, et al.
Publicado: (2019)

Combination of Colistin and Azidothymidine Demonstrates Synergistic Activity against Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae
por: Chang, Ya-Ting, et al.
Publicado: (2020)

Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
por: Huang, Po-Han, et al.
Publicado: (2022)

Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients
por: Xie, Yue-liang, et al.
Publicado: (2022)

Modulating the transcriptomic profile of multidrug-resistant Klebsiella pneumoniae biofilm formation by antibiotics in combination with zinc sulfate
por: Shebl, Rania I., et al.
Publicado: (2023)

Evaluation of Bacteriophage Cocktail on Septicemia Caused by Colistin-Resistant Klebsiella pneumoniae in Mice Model
por: Singh, Aprajita, et al.
Publicado: (2022)

In Vitro antibiotic combinations of Colistin, Meropenem, Amikacin, and Amoxicillin/clavulanate against multidrug-resistant Klebsiella pneumonia isolated from patients with ventilator-associated pneumonia
por: Bayatinejad, Ghazal, et al.
Publicado: (2023)

mcr-1 Colistin Resistance in ESBL-Producing Klebsiella pneumoniae, France
por: Caspar, Yvan, et al.
Publicado: (2017)

Analysis of colistin resistance in carbapenem-resistant Enterobacterales and XDR Klebsiella pneumoniae
por: Bir, Raunak, et al.
Publicado: (2022)

Evaluation of Chemical Changes in Laboratory-Induced Colistin-Resistant Klebsiella pneumoniae
por: Pruss, Agata, et al.
Publicado: (2021)

Heteroresistance to Colistin in Clinical Isolates of Klebsiella pneumoniae Producing OXA-48
por: Sánchez-León, Irene, et al.
Publicado: (2023)

Insight into Antibiotic Synergy Combinations for Eliminating Colistin Heteroresistant Klebsiella pneumoniae
por: Rajakani, Sahaya Glingston, et al.
Publicado: (2023)

Novel colistin-EDTA combination for successful eradication of colistin-resistant Klebsiella pneumoniae catheter-related biofilm infections
por: Shein, Aye Mya Sithu, et al.
Publicado: (2021)

Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates
por: Ontong, Julalak C., et al.
Publicado: (2021)

The secondary resistome of multidrug-resistant Klebsiella pneumoniae
por: Jana, Bimal, et al.
Publicado: (2017)

Efficacy of Intravenous Colistin Monotherapy Versus Colistin Combined With Meropenem in Patients With Multidrug-Resistant Infections: A Retrospective Observational Study
por: Baig, Mehwish, et al.
Publicado: (2023)

Collateral damage of using colistin in hospitalized patients on emergence of colistin-resistant Escherichia coli and Klebsiella pneumoniae colonization and infection
por: Wangchinda, W., et al.
Publicado: (2018)

Eugenol works synergistically with colistin against colistin-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae isolates by enhancing membrane permeability
por: Kong, Jingchun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nhcfi94kjilnpg8crps8sednoh